
USFDA APPLICATION NUMBER - 213135 / DOSAGE - TABLET;ORAL - 0.225GM;0.188GM;1.479GM
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| MAGNESIUM SULFATE ANHYDROUS(UNII: ML30MJ2U7I) (MAGNESIUM CATION - UNII:T6V3LHY838) | MAGNESIUM SULFATE ANHYDROUS | 2.7g |
| POTASSIUM CHLORIDE(UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152) | POTASSIUM CATION | 2.25g |
| SODIUM SULFATE(UNII: 0YPR65R21J) (SODIUM SULFATE ANHYDROUS - UNII:36KCS0R750) | SODIUM SULFATE | 17.75g |
Inactive Ingredients
| Ingredient Name | Braintree Laboratories, Inc. |
|---|---|
| ETHYLENE GLYCOL(FC72KVT52F) | |
| POLYETHYLENE GLYCOL 8000(Q662QK8M3B) | |
| POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW)(23ZQ42JZZH) | |
| SODIUM CAPRYLATE(9XTM81VK2B) |